
Why Perfect Clinical Trial Data Is A Dangerous Myth
By Dan Schell, Chief Editor, Clinical Leader Kara Harrison I’ve interviewed former FDA investigators before, and each time I come away equal parts entertained and alarmed. Talking to Kara Harrison was no exception. Her résumé spans grading orange juice at …